The Classification of Cardiomyopathies

  • G. Sinagra
  • L. Mestroni
  • F. Camerini
Conference paper


The term cardiomyopathy was probably used for the first time in 1957, when W. Bridgen [1] described the diseases of the myocardium of “non-coronary ” etiology. Previously, a variable terminology had been used for these diseases, such as “myocardosis ” /“cardiac myopathy ”, “myocarditis ” etc.


Dilate Cardiomyopathy Hypertrophic Cardiomyopathy Restrictive Cardiomyopathy Regulatory Myosin Light Chain Myosin Binding Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bridgen W (1957) Uncommon myocardial diseases: the non-coronary cardiomyopathies. Lancet 2:1179–1184, 1243–1249Google Scholar
  2. 2.
    Goodwin JK, Gordon H, Hollman A, Bishop MB (1961) Clinical aspects of cardiomyopathy. Br Heart J 1:69–79Google Scholar
  3. 3.
    Report of the International Society and Federation of Cardiology/World Health Organization. Task Force on the definition of cardiomyopathies (1980) Br Heart J 44:672–673CrossRefGoogle Scholar
  4. 4.
    Report of the 1995 World Health Organization/International Society and Federation of Cardiology. Task Force on the Definition and Classification of Cardiomyopathies. Circulation (1996) 93:841–842CrossRefGoogle Scholar
  5. 5.
    Bagger JP, Baandrup U, Rasmussen K, Moller M, Vesterlund Y (1984) Cardiomyopathy in western Denmark. Br Heart J 52:327–331PubMedCrossRefGoogle Scholar
  6. 6.
    Rakar S, Sinagra G, Di Lenarda A, Poletti A, Bussani R, Silvestri F, Camerini F (1997) Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. Eur Heart J 18:117–123Google Scholar
  7. 7.
    Williams DG, Olsen EGJ (1985) Prevalence of overt dilated cardiomyopathy in two regions of England. Br Heart J 54:153–155PubMedCrossRefGoogle Scholar
  8. 8.
    Codd MB, Sugrue DD, Gerts BJ, Melton III LJ (1989) Epidemiology of idiopatic dilated and hypertrophic cardiomyopathy. Circulation 80:564–572PubMedCrossRefGoogle Scholar
  9. 9.
    Petitjean J, Kopecka H, Freymuth F, Langlard JM, Scanu P, Galateau F, Bouhour JB, Fernere M, Charbonneau P, Komajda M (1992) Detection of enteroviruses in endomyocardial biopsy by molecular approach. J Med Virol 37:76–82PubMedCrossRefGoogle Scholar
  10. 10.
    Grasso M, Arbustini E, Silini E, Diegoli M, Percivalle E, Ratti G, Bramerio M, Gavazzi A, Vigano M, Milanessi G (1992) Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polimerase chain reaction. Am J Cardiol 69:658–664PubMedCrossRefGoogle Scholar
  11. 11.
    Fujioka S, Koide H, Kitaura Y, Deguchi H, Kawamura K (1995) Analysis of enterovirus genotypes using single-strand conformation polymorphisms of polymerase chain reaction products. J Virol Methods 51:253–258PubMedCrossRefGoogle Scholar
  12. 12.
    Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeneffer RJ, Cheesbro JN, Tazelaar H (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopatic dilated cardiomyopathy. N Engl J Med 326:77–82PubMedCrossRefGoogle Scholar
  13. 13.
    Mestroni L, Miani D, Di Lenarda A, Silvestri F, Bussani R, Filippi G, Camerini F (1990) Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 65:1449–1453PubMedCrossRefGoogle Scholar
  14. 14.
    Rocco C, Gregori D, Miocic S, Di Lenarda A, Sinagra G, Caforio AL, Vatta M, Matulic M, Zerjal T, Giacca M, Mestroni L (1997) New insights into the genetics of dilated cardiomyopathy. Circulation [Suppl.] 96:I–696Google Scholar
  15. 15.
    Caforio ALP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Boltazzo GF, McKenna WJ (1994) Autoimmunity in dilated cardiomyopathy:evidence from family studies. Lancet 344:773–777PubMedCrossRefGoogle Scholar
  16. 16.
    Keren A, Gottlieb S, Tzivoni D, Stern S, Yarom R, Billingham ME, Popp RL (1990) Mildly Dilated Congestive Cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation 81:506–517Google Scholar
  17. 17.
    Schwartz K, Mercadier JJ (1996) Molecular and cellular biology of heart failure. Curr Opin Cardiol 11:227–236PubMedCrossRefGoogle Scholar
  18. 18.
    Watkins H, Rosenzweig A, Hwang D-SH, Levi T, McKenna W, Seidman CE, Seidman JG (1992) Characteristics and prognostic implication of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326:1108–1114PubMedCrossRefGoogle Scholar
  19. 19.
    Siegel RJ, Shah PK, Fishbein MC (1984) Idiopatic restrictive cardiomyopathy. Circulation 70:165–169PubMedCrossRefGoogle Scholar
  20. 20.
    Boffa GM, Thiene G, Nava A, Dalla Volta S (1991) Cardiomyopathy:a necessary revision of the WHO classification. Int J Cardiol 30:1–7PubMedCrossRefGoogle Scholar
  21. 21.
    McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218PubMedCrossRefGoogle Scholar
  22. 22.
    Camerini F, Mestroni L, Perkan A, Pinamonti B, Sinagra G (1993) La classificazione delie cardiomiopatie: È opportuna una revisione? G Ital Cardiol 23:729–733PubMedGoogle Scholar
  23. 23.
    Malik MSA, Watkins H (1997) The molecular genetics of hypertrophic cardiomyopathy. Curr.Opinion Cardiol 12:295–302CrossRefGoogle Scholar
  24. 24.
    Mestroni L, Giacca M (1997) Molecular genetics of dilated cardiomyopathy. Curr Opinion Cardiol 12:303–309CrossRefGoogle Scholar
  25. 25.
    Goodwin JF (1982) The frontiers of cardiomyopathy. Br Heart J 48:1–18.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • G. Sinagra
  • L. Mestroni
  • F. Camerini

There are no affiliations available

Personalised recommendations